Genome-wide association studies (GWAS) have shown that a single-nucleotide polymorphism (SNP) affecting the transcription factor Eomesodermin (EOMES) is associated with a significantly increased risk to develop chronic lymphocytic leukemia (CLL) [1]. Here, EOMES is linked to B-cell chronic lymphocytic leukemia.